Current labeling advises matching the inhaled insulin units to the injected mealtime dose of rapid-acting insulin analog.

Most patients with type 1 diabetes using an inhaled insulin increased their daily insulin dose by more than 4 U from baseline ...

Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 ...

In a phase 2 trial of peanut oral immunotherapy (OIT) involving 21 adults, 67% achieved maintenance dose tolerance, with the median tolerated dose increasing 100-fold from 30 mg to 3000 mg.

After reaching the METH dose of 0.75 mg/kg b.i.d. (METH Maintenance) the animals were ... Data are reported as mean±SEM. Total 24 h urinary excretion of METH and its active metabolite AMPH ...